Scarica l'app Stockscreener
11.56
0.69%
-0.08
Dopo l'orario di chiusura:
11.79
0.23
+1.99%
Precedente Chiudi:
$11.64
Aprire:
$11.65
Volume 24 ore:
1.15M
Relative Volume:
1.29
Capitalizzazione di mercato:
$1.23B
Reddito:
$247.00M
Utile/perdita netta:
$-249.00M
Rapporto P/E:
-3.7411
EPS:
-3.09
Flusso di cassa netto:
$-267.00M
1 W Prestazione:
+8.95%
1M Prestazione:
+25.24%
6M Prestazione:
+19.30%
1 anno Prestazione:
-29.17%
Intervallo 1D:
$11.28
$11.69
Intervallo di 1 settimana:
$10.39
$11.84
Portata 52W:
$6.50
$18.98
Arcus Biosciences Inc Stock (RCUS) Company Profile
Nome
Arcus Biosciences Inc
Settore
Industria
Telefono
(510) 694-6200
Indirizzo
3928 POINT EDEN WAY, HAYWARD, CA
Confronta RCUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
11.56 | 1.15B | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | Iniziato | H.C. Wainwright | Neutral |
| 2024-10-08 | Iniziato | Wells Fargo | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Neutral |
| 2022-10-11 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2020-11-24 | Iniziato | Berenberg | Buy |
| 2020-11-23 | Iniziato | Evercore ISI | Outperform |
| 2020-04-03 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-03-04 | Iniziato | Barclays | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-09-27 | Iniziato | Mizuho | Buy |
| 2019-05-24 | Ripresa | Citigroup | Buy |
| 2018-10-09 | Iniziato | Wedbush | Outperform |
| 2018-04-09 | Iniziato | Citigroup | Buy |
| 2018-04-09 | Iniziato | Goldman | Neutral |
| 2018-04-09 | Iniziato | Leerink Partners | Outperform |
Mostra tutto
Arcus Biosciences Inc Borsa (RCUS) Ultime notizie
Transcript : Arcus Biosciences, Inc. Presents at Citi's Biopharma Back to School Conference, Sep-03-2025 11 - MarketScreener
Will Arcus Biosciences Inc. see short term momentumJuly 2025 Setups & Technical Confirmation Trade Alerts - Newser
Why Arcus Biosciences Inc. is moving todayMarket Risk Analysis & Daily Profit Focused Screening - Newser
Smart tools for monitoring Arcus Biosciences Inc.’s price actionWeekly Profit Report & High Accuracy Swing Entry Alerts - Newser
Arcus Biosciences Inc.’s volatility index tracking explainedJuly 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
Using Ichimoku Cloud for Arcus Biosciences Inc. technicalsJuly 2025 Market Mood & Safe Entry Trade Reports - Newser
Arcus Biosciences Inc. stock trend forecastTrade Signal Summary & High Win Rate Trade Tips - Newser
Is Arcus Biosciences Inc. forming a bottoming baseJuly 2025 Review & Weekly High Potential Alerts - Newser
Strategies to average down on Arcus Biosciences Inc.July 2025 Outlook & Consistent Profit Alerts - Newser
Applying Wyckoff theory to Arcus Biosciences Inc. stock2025 Market Outlook & Real-Time Buy Zone Alerts - Newser
Arcus Biosciences Inc. stock daily chart insightsJuly 2025 Snapshot & Safe Capital Allocation Plans - Newser
Key Cancer Drug Trial Results Coming: Arcus Biosciences to Reveal Casdatifan Data for Kidney Cancer - Stock Titan
News impact scoring models applied to Arcus Biosciences Inc.July 2025 Patterns & Daily Profit Maximizing Tips - Newser
What moving averages say about Arcus Biosciences Inc.2025 Major Catalysts & Technical Entry and Exit Tips - Newser
What to do if you’re stuck in Arcus Biosciences Inc.Earnings Beat & AI Enhanced Execution Alerts - Newser
Backtesting results for Arcus Biosciences Inc. trading strategiesEarnings Growth Report & Free Fast Gain Swing Trade Alerts - Newser
Is Arcus Biosciences Inc. stock bottoming out2025 Price Momentum & Risk Managed Trade Strategies - Newser
Using Bollinger Bands to evaluate Arcus Biosciences Inc.2025 Market WrapUp & Safe Capital Allocation Plans - Newser
What recovery options are there for Arcus Biosciences Inc.July 2025 Institutional & Stepwise Swing Trade Plans - Newser
Is Arcus Biosciences Inc. stock a smart retirement pickQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - khodrobank.com
Is Arcus Biosciences Inc. stock technically oversold2025 Bull vs Bear & Low Risk High Reward Trade Ideas - khodrobank.com
Is Arcus Biosciences Inc. forming higher highs and higher lows2025 Trading Volume Trends & Stock Portfolio Risk Management - khodrobank.com
Sector ETF performance correlation with Arcus Biosciences Inc.2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Arcus Biosciences Inc. Outperforms Peers on Volume Metrics getLinesFromResByArray error: size == 0 - kangso.co.kr
What to expect from Arcus Biosciences Inc. in the next 30 daysEarnings Growth Report & Safe Capital Growth Plans - Newser
Chart overlay techniques for tracking Arcus Biosciences Inc.Quarterly Portfolio Report & Real-Time Volume Analysis - Newser
Leading vs lagging indicators on Arcus Biosciences Inc. performanceJuly 2025 Momentum & Risk Controlled Swing Trade Alerts - Newser
Arcus Biosciences Inc. stock retracement – recovery analysisJuly 2025 PostEarnings & Weekly Hot Stock Watchlists - Newser
Will Arcus Biosciences Inc. bounce back from current supportJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - Newser
Trendlines Suggest Arcus Biosciences Inc. May Bottom Out Soon getLinesFromResByArray error: size == 0 - kangso.co.kr
Candlestick signals on Arcus Biosciences Inc. stock todayWeekly Stock Analysis & Daily Price Action Insights - Newser
How to escape a deep drawdown in Arcus Biosciences Inc.July 2025 News Drivers & High Conviction Buy Zone Picks - Newser
Arcus Biosciences Inc Azioni (RCUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):